Related Experiment Video
Updated: Oct 15, 2025

09:43
Isolation, Culture, and Characterization of Prostate Cancer-Associated Fibroblasts
Published on: August 1, 2025
295
Fibroblast heterogeneity in prostate carcinogenesis.
Sathyavathi ChallaSivaKanaka1, Renee E Vickman1, Mamatha Kakarla1
1Department of Surgery, NorthShore University HealthSystem, Research Institute, 1001 University Place, Evanston, IL, 60201, USA.
Cancer Letters
|October 29, 2021
Summary
Cancer-associated fibroblasts (CAFs) are key players in prostate cancer (PCa) progression, promoting growth and remodeling the tumor microenvironment. Understanding CAF heterogeneity is crucial for developing effective PCa treatments.
Area of Science:
- Oncology
- Cancer Biology
- Tumor Microenvironment Research
Background:
- Cancer-associated fibroblasts (CAFs) were once considered passive bystanders but are now recognized as active contributors to prostate cancer (PCa) development.
- CAFs exhibit multifaceted roles, including promoting cancer cell proliferation, migration, and altering the tumor microenvironment.
- Significant intrinsic cellular heterogeneity within CAFs presents a challenge for understanding their precise functions and interactions in PCa.
Purpose of the Study:
- To discuss the origins, molecular, and functional heterogeneity of CAFs in prostate cancer.
- To highlight the challenges in delineating CAF heterogeneity.
- To identify potential research avenues for a deeper understanding of CAFs' role in PCa tumorigenesis.
Main Methods:
- Review and discussion of existing literature on CAF heterogeneity in PCa.
- Analysis of the complex interactions between CAF subpopulations and other cellular components of the tumor microenvironment.
- Identification of critical signaling pathways involved in CAF-driven tumorigenesis.
Main Results:
- CAFs are integral to prostate cancer progression, influencing tumor growth and microenvironment dynamics.
- The heterogeneity of CAFs is substantial but not fully characterized, complicating therapeutic targeting.
- Interactions between CAF subpopulations and between CAFs and epithelial cells are not well-defined.
Conclusions:
- Defining the heterogeneity and interactions of CAFs is essential for understanding their role in PCa.
- Addressing the challenges in delineating CAF heterogeneity will pave the way for novel therapeutic strategies.
- Further research into CAF origins, functions, and signaling is critical for advancing PCa treatment.

